- A New Frontier for Convergence in Gastroenterology and Hepatology
Nov. 29(Fri) 14:00-15:30 |
Battle against cholangiocarcinoma: bench to clinical application | Diamond Hall (3F) |
Chair(s) | Hong-Sik Lee (Korea), Chang-Nyol Paik (Korea) | |
14:00-14:22 | Genetic and transcriptomic analyses of the biliary tract cancer | Tatsuhiro Shibata (Japan) |
14:22-14:44 | Development of patient-derived preclinical models for cholangiocarcinoma | Yun-Hee Kim (Korea) |
14:44-15:06 | Circulating biomarkers in cholangiocarcinoma | Nai-Jung Chiang (Taiwan) |
15:06-15:28 | Developmental therapeutics | Seungmin Bang (Korea) |
Nov. 29(Fri) 16:00-17:30 |
Toward the Precision Medicine | Diamond Hall (3F) |
Chair(s) | Laufey Amundadottir (USA), Tae Il Kim (Korea), Sun Young Rha (Korea) | |
16:00-16:20 | Expression quantitative trait locus (eQTL) and chromatin interaction approaches to understand biology of pancreatic cancer risk loci from GWAS | Laufey Amundadottir (USA) |
16:20-16:40 | Exploration of aminoacyl-tRNA synthetases for future medicine | Sunghoon Kim (Korea) |
16:40-17:00 | TGFß signalling and NFAT transcription factors in cancer development and progression | Volker Ellenrieder (Germany) |
17:00-17:20 | Intrinsic Cancer Vaccination | In San Kim (Korea) |
17:20-17:30 | Q&A |
Nov. 30(Sat) 11:00-12:30 |
Go to the deep inside of GI disease | Emerald Hall A (3F) |
Chair(s) | Tae Il Kim (Korea), Thomas Roberts (USA) | |
11:00-11:22 | Recent update of physiology research of GI sensation and motility | Jae Hak Kim (Korea) |
11:22-11:44 | The future of PI3K directed therapies in cancer treatment | Thomas Roberts (USA) |
11:44-12:06 | Recent update of brain-gut-microbiome axis | Geom Seog Seo (Korea) |
12:06-12:28 | Recent update of pathophysiology and therapeutic target of IBD | Seongjoon Ko (Korea) |